Cancer cells may escape the host immune response by expressing immune checkpoint molecules, such as cytotoxic T-lymphocyte associated antigen 4 (CTLA-4) and programmed death ligand 1 (PD-L1), which block T-cell activation and proliferation. Here, CTLA4 is linked to cancer.